Gen Surg Cases · vascular
Day-6 post-colectomy cancer leg swelling on 1-week prophylaxis — Wells-gated duplex, 4-week extension, and provoked-duration counselling
Fellowship clinical-management station on postoperative cancer-surgery DVT: Wells-gated diagnosis, duplex confirmation, ENOXACAN-II 4-week extension, Caprini highest-risk framing, provoked-duration planning, and PTS counsel.
On this page
Study tools
Target exams
Candidate tasks and model management
Score Wells before touching the ultrasound probe. Her swollen cancer-surgery leg is high pretest probability until shown otherwise — and high probability carries 75% DVT prevalence against 3% for low and 17% for moderate, with only 0.6% events in ruled-out patients at 3 months — so score first, because the score decides whether a negative scan reassures or re-tests.[1]
Confirm with duplex, and know what the scan can and cannot say. Pooled duplex sensitivity is 94.2% for proximal disease with 93.8% specificity — duplex technique 96.5% sensitive, compression alone 93.8% with 97.8% specificity — so a positive proximal scan treats, while distal sensitivity of 63.5% (56.8% compression alone) means a distal-only question earns surveillance rather than complacency, and repeat scanning yields only 1.3%.[3]
Extend prophylaxis thinking to 4 weeks — her chart is the error. She sits in the Caprini highest band (malignancy plus major open abdominal surgery), where 30-day VTE reaches 1.94% and over half of all surgical inpatients land — so name her band aloud.[7] Then fix the stop date: 4 weeks of enoxaparin after abdominal or pelvic cancer surgery gives venographic VTE 4.8% against 12.0% for 1 week (persisting 5.5 versus 13.8% at 3 months) with no bleeding or complication difference — extend, do not stop at day 7.[8]
Set a provoked-duration plan and counsel PTS by name. Her surgical trigger halves recurrence risk (hazard ratio 0.36) against cancer at 1.72 — so plan duration-limited therapeutic cover with a stop date, unlike unprovoked disease that extends.[19] Counsel the leg's future explicitly: post-thrombotic syndrome reaches 22.8% at 2 years and 28–29% at 5–8 years, ipsilateral recurrence multiplies PTS risk 6.4-fold, and severity is graded by the Villalta scale — the 1994 disease-specific questionnaire correlating with severity scores and venous filling — so recurrence prevention is PTS prevention, and routine post-DVT stockings earn no prescription.[19][25]
References6ShowHide
- [1]Wells PS, et al. Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet, 1997.PMID 9428249
- [3]Goodacre S, et al. Systematic review and meta-analysis of the diagnostic accuracy of ultrasonography for deep vein thrombosis. BMC Med Imaging, 2005.PMID 16202135
- [7]Bahl V, et al. A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg, 2010.PMID 19779324
- [8]Bergqvist D, et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med, 2002.PMID 11919306
- [19]Prandoni P, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med, 1996.PMID 8644983
- [25]Lattimer CR, et al. Validation of the Villalta scale in assessing post-thrombotic syndrome using clinical, duplex, and hemodynamic comparators. J Vasc Surg Venous Lymphat Disord, 2014.PMID 26992962